Project Grant R01NS138297
Award Date
8/1/24
Completion Date
7/31/29
Dollars Obligated
$625K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
This Project Grant award, totaling $2,130,388.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award aims to improve understanding of why some stroke patients have poor outcomes despite successful recanalization (reopening of blocked blood vessels). The key products and services to be delivered include: Developing a longitudinal...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $423,500 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the Augusta University Research Institute, Inc. The objective is to develop and evaluate engineered exosomes carrying neuron-targeting peptides and a therapeutic protein (neuroglobin) for treating ischemic stroke. The research will: 1) characterize the engineered exosomes and assess their...
This federal Project Grant award for $853,135 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant will fund research at Dignity Health's St. Joseph's Hospital and Medical Center in Phoenix, AZ to study the role of the complement C3A receptor in exacerbating brain injury and functional impairment following ischemic stroke. The research aims to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, is focused on defining the contribution of endothelial cell sphingolipid metabolism to outcomes of acute ischemic stroke in mice. The $192,500 award to the University of Utah aims to (1) determine whether interventions targeting cerebral endothelial cells can improve stroke...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $502,929 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to The Feinstein Institutes for Medical Research. The objective of this 4-year grant, with an award date of September 1, 2024, is to evaluate the impact of the Heat Vulnerability Index (HVI) on stroke functional outcomes in individuals with Alzheimer's disease and related dementias. The HVI, developed...
This $834,094 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to advance research on post-stroke cognitive impairment and dementia (PSCID). The funding will support a multi-year effort leveraging a national stroke registry and Medicare data to determine the incidence and prevalence of PSCID, identify associated risk factors, and explore potential pharmacological prevention strategies. Key aspects of the research include a patient-centered approach,...
The University of Rhode Island Research Office received a $413,729 Project Grant award on September 22, 2023 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The funding will support research to investigate the molecular links between stroke, the actin cytoskeleton, and Alzheimer's disease pathogenesis. The proposed work will use induced...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a 2-year, $423,500 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to Wayne State University in Detroit, MI. The objective of this high-risk, high-reward research project is to investigate the use of remotely administered hypothermia (RAH) to the spleen as a novel neuroprotective therapy for ischemic stroke. The research aims to determine if suppressing splenic...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $1,223,140 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the University of Chicago to test a novel biopharmaceutical agent called Sanguinate for mitigating cerebral infarct growth in acute ischemic stroke. The objective is to evaluate Sanguinate's ability to boost arterial collateralization and deliver oxygen to ischemic brain tissue, with the goal of...
This Project Grant award of $2,403,545 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), supports research to examine the epigenetic mechanisms linking social determinants of health (SDOH) exposures to vascular cognitive impairment and dementia (VCID) after intracerebral hemorrhage (ICH) stroke. The research, titled REACH-EPIVCID, will identify...